Skip to main content

Israeli supermarket giant to sell low-cost medical cannabis - Haaretz.com

Israeli supermarket giant to sell low-cost medical cannabis - Haaretz.com

Israel’s discount supermarket king Rami Levy is planning to do for medical marijuana what he did for fresh chicken and, in the future, add cannabis as a consumer product too.

Under a memorandum of understanding signed this week with the cannabis company Together, his Good Pharm chain of 28 drug stores will begin selling medical marijuana at discounted prices. In an interview with TheMarker, Good Pharm’s co-founder Adam Friedler and Together CEO Nissim Bracha promised a price revolution ahead for the more than 74,000 Israelis with doctors’ approval to use cannabis.

Bibi gets immunity – just not the kind he really wants. LISTEN to Haaretz Weekly podcast

Subscribe

But that’s just the beginning. Friedler said Good Pharm was looking ahead to the day when cannabis becomes another consumer product.

“I think that the minute the cannabis market is open to recreational use and no longer limited to those with approvals, it will turn into a really big market and there will be big demand in city centers, where our stores are located. Cannabis products will become commodity products and price will be an important factor for consumers, as has happened with basic consumer goods,” said Friedler.

The move comes as the Health Ministry seeks to cut the cost of medical marijuana through a pilot program that grants Israeli companies export licenses in exchange for discounting prices in the domestic market. For many, it’s a worthwhile trade-off: The Israeli medical-marijuana market is worth about 750 million shekels ($233 million) annually, but export markets could potentially be worth many times that.

Under the pilot, due to end in another two weeks, local prices range from 140 to 220 shekels for 10 kilograms, compared with the normal range of 200 to 300 shekels. However, two thirds of marijuana products in the market aren’t in the pilot, including what critics say are the most popular ones.

“We’ll offer three varieties exclusive to the pharmacies in Good Pharm and they’ll sell them for 100 to 120 shekels per 10 grams – half the price of similar products in the market today,” said Bracha. “We’re committed to offering the lowest prices in Israel even if at some point prices rise.”

Bracha said he would be able to sell medical marijuana at much lower prices because Together controls the entire supply chain. “We don’t need to buy plants. We have a factory, packing house and now we’ll have pharmacies,” he explains.

The cost of growing a cannabis plant accounts for 3.30 shekels per gram and packing adds another 2.70. Processing and quality control cost another shekel and distribution and other costs amount to 1.50 shekels, bringing the total to just 10 shekels a gram for medical marijuana. Pharmacy chains have their overhead costs and minimum profit margins as well, which adds to the final price.

Together operates 20 dunams (five acres) of cannabis hothouses in Israel and another 32 in Uganda. Its Globus Pharma unit operates a processing plant that meets the IMC-GMP standards. This week, the company said it reached a 20 million shekel loan agreement with Mizrahi Tefahot Bank, some of which can be converted into shares.

Good Pharm will be selling exclusively two varieties of T20 medical marijuana, which Bracha termed “popular” in the Israeli market because of its high rate of THC – cannabis’ main psychoactive compound. It will also sell T10, which is used by the elderly and other people seeking to maintain their level of function.

When a final agreement is signed, the first phase, due to get underway in the second quarter of next year, the products will be sold at two or three Good Pharms where the two sides will open dedicated cannabis pharmacies inside the store (despite its name, Good Pharm does not sell prescription drugs). After that, they will open one new pharmacy a month.

The government has said it intends to exclude CBD, a non-psychoactive cannabis ingredient, from the Dangerous Drugs Ordinance, allowing it to be used in products like food, beverages and cosmetics. The Israeli CBD-product market could reach sales of $300 million to $475 million within five years, and the global market could be worth $30 billion, according to the consulting and accounting firm Deloitte Israel.

“There’s going to be a complete industry in Israel around cannabis products and it will be much easier for a druggist to recommend and sell them if they are available on store shelves,” said Friedler.

Let's block ads! (Why?)



https://www.haaretz.com/israel-news/.pre...-1.9396335

from potads 420 forums for free advertising your products - All Forums learn more

Popular posts from this blog

Martha Stewart launches CBD line in crowded market - CNN

Martha Stewart launches CBD line in crowded market - CNN The hemp-derived, cannabidiol-rich gummies, soft gels and oil drops officially launched on Thursday after more than a year in development. The products are the result of the style maven's partnership with Canopy Growth ( CGC ) , the Canadian cannabis company with a multibillion-dollar backer in US alcohol giant Constellation Brands ( STZ ) . Stewart joined Canopy as an adviser in early 2019 for the express purpose of developing cannabis products for humans and their pets after being introduced to Canopy's founder by her friend Calvin Broadus Jr. -- the rapper and businessman better known as Snoop Dogg. His Leafs by Snoop cannabis brand is produced by Canopy. The initial Martha Stewart CBD products, which range from $34.99 to $44.99, will be sold online at Canopy's e-commerce site . The pet products are expected to debut later this year. "I was surprised to learn that while most people have heard of ...
Read more

The Half-Legal Cannabis Trap - POLITICO

The Half-Legal Cannabis Trap - POLITICO LOS ANGELES — Everything about Kelvin’s job in a neighborhood southwest of downtown seemed like any other assignment, if not a little more exciting. The 40-year-old, who had previously worked as an electrician, had been employed since 2015 by a private security company that contracted him out to guard marijuana dispensaries. In 2019, he was protecting one of the thousand or so cannabis stores in California’s biggest city—part of an industry that has grown less and less underground since 1996, when the state first legalized medical marijuana. Kelvin, who asked not to be identified beyond his middle name to avoid professional retaliation, doesn’t smoke pot, but says the gig felt like the future. He grew up in a time when other Black people he knew in Los Angeles would go to jail for possessing even small amounts of the drug. Now, customers could walk into shops like the one he was guarding, many of which can be identified by green crosses on...
Read more

Cannabis news worldwide -- Some Indian farmers are turning moon-gazers

Some Indian farmers are turning moon-gazers A growing number of cultivators opt for biodynamic techniques to give farming a zodiac twist Sarvdaman Patel , 69, stands between rows of legumes and parsley at high noon, but it is not the harsh sun that bothers him. He is obsessed with the moon. "It is currently in the Air sign which is ideal for flowering plants," he remarks, peering at the marigolds. Patel is no Bejan Daruwala. He is an Indian farmer who has been using biodynamic (BD) techniques for the last 16 years on his farm in Gujarat's Anand. The BD cultivation calendar is based on the moon's movement through each zodiac every two-and-a-half days covering all 12 signs every month. An unofficial estimate by the Biodynamic Association of India (BDAI) says about one lakh farmers in Maharashtra, Andhra Pradesh, Punjab and Uttarakhand practise biodynamic farming. However, most of the produce is sold under the generic 'organic' label as few consumers unde...
Read more